Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. - Test2 - elhamkhani - TriplyDB

Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2.

Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2.

http://www.wikidata.org/entity/Q34381015

about

Endoglin mediates fibronectin/α5β1 integrin and TGF-β pathway crosstalk in endothelial cells TIMAP, a novel CAAX box protein regulated by TGF-beta1 and expressed in endothelial cells Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia Biomedicine and diseases: the Klippel-Trenaunay syndrome, vascular anomalies and vascular morphogenesis Regulation of ALK-1 signaling by the nuclear receptor LXRbeta Casein kinase 2beta as a novel enhancer of activin-like receptor-1 signaling Bone morphogenetic protein (BMP) and activin type II receptors balance BMP9 signals mediated by activin receptor-like kinase-1 in human pulmonary artery endothelial cells A gene for inherited cutaneous venous anomalies ("glomangiomas") localizes to chromosome 1p21-22.Hereditary haemorrhagic telangiectasia: a clinical and scientific review Genetic risk factors for hepatopulmonary syndrome in patients with advanced liver disease High-resolution transcript map of the region spanning D12S1629 and D12S312 at chromosome 12q13: triple A syndrome-linked region Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease Bone morphogenetic protein-9 is a circulating vascular quiescence factor Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis The activin receptor-like kinase 1 gene: genomic structure and mutations in hereditary hemorrhagic telangiectasia type 2 Genomic approaches to research in pulmonary hypertension Growth factor signaling in lung morphogenetic centers: automaticity, stereotypy and symmetry Diffuse Pulmonary Arteriovenous Fistulas With Pulmonary Arterial Hypertension: Case Report and Review Effective treatment of gastrointestinal bleeding with thalidomide--Chances and limitations BMPs and their clinical potentials The molecular genetics and cellular mechanisms underlying pulmonary arterial hypertension Developmental and pathological angiogenesis in the central nervous system Vascular anomalies: from genetics toward models for therapeutic trials The genetics of pulmonary arterial hypertension Context-specific interactions between Notch and ALK1 cannot explain ALK1-associated arteriovenous malformations.Mononuclear cells and vascular repair in HHT Functional and splicing defect analysis of 23 ACVRL1 mutations in a cohort of patients affected by Hereditary Hemorrhagic Telangiectasia Crystal structure of BMP-9 and functional interactions with pro-region and receptors Chromosomal localization of three human genes encoding members of the TGF-beta superfamily of type I serine/threonine kinase receptors Incomplete penetrance and phenotypic variability characterize Gdf6-attributable oculo-skeletal phenotypes Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice Enhanced responses to angiogenic cues underlie the pathogenesis of hereditary hemorrhagic telangiectasia 2 Identification of endoglin in rat hepatic stellate cells: new insights into transforming growth factor beta receptor signaling ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2 A murine model of hereditary hemorrhagic telangiectasia Mutation study of Spanish patients with hereditary hemorrhagic telangiectasia Real-time imaging of de novo arteriovenous malformation in a mouse model of hereditary hemorrhagic telangiectasia.Interaction between alk1 and blood flow in the development of arteriovenous malformations Deletion of Rbpj from postnatal endothelium leads to abnormal arteriovenous shunting in mice.BMP signaling modulation attenuates cerebral arteriovenous malformation formation in a vertebrate model

P2860

fd01abae184af73ec971b29364c1d879a4323a31

P248

Q24297899-7FA42220-104E-4832-92A3-F6697CA4C62A Q24299382-3FA60AA3-186D-49D9-9DCB-CED3752235FA Q24302138-125434AC-2349-496E-9740-773B32C27292 Q24302790-F9F2A8B1-8404-423D-A08D-550DA0404AFD Q24312839-2C0DEF67-14BE-4A52-A0DC-D84420D7FE92 Q24313348-3482845D-79E3-4DFB-A0F7-AAEE773ECF29 Q24315838-CEB87AD3-6370-480B-B3FB-9BBB3F43E15F Q24540299-30DC5311-FC3D-44A2-8521-51478FE9D7AC Q24600839-726D6C20-AD19-430E-A8BD-E7322825C7C1 Q24604623-4800CDAE-A761-45C9-BF9E-8D7F47789D70 Q24622783-733CB946-3242-400B-BACD-3E7BFC29DE35 Q24645017-6BF1F019-2346-4F7B-8F48-3F806CB6B347 Q24657942-6DF05C99-9D33-48C9-8A6E-8A45521A992F Q24677057-DB4FB8BA-AA79-4EDB-BB02-6DCD8A79872C Q24678806-FE711BF5-B088-425F-925D-A8915DFA3C4C Q24792044-BFCA396B-92D0-459A-B777-CE7F1ADA33EC Q24795748-16DD2FA4-5EB7-44CD-82A9-3AEC9CEC0F9C Q26750721-C217B3D1-EC26-4E29-A8A2-2E45299D4E2E Q26752740-EC8B3A74-0CC0-4674-804B-7B83099D40DB Q26824827-7881061E-3EDF-4274-80E1-81C61DBD77F3 Q26992278-C3E305F3-C109-46EE-8349-42B790398FDF Q27023250-D42552D6-F944-4191-ABC4-8C2CC1CC8FDA Q27025402-FB50E149-A4E6-4DCF-965E-B86E5976D25B Q27027507-4CACAB59-89D4-457E-AC3C-3684E5273683 Q27302123-1F775490-7B29-4D90-A46A-CBBF7F40FDFE Q28084374-55EB3AE9-4EE6-4D76-916E-8AF3098CBB37 Q28116278-BD1DC516-E8E0-490E-8941-6BCA4EB1C226 Q28246829-DE5101C7-E5E2-4EFD-8FCE-BC34F88EB94D Q28264657-F1C93B6C-C43C-4F36-8C13-35EFF6853CA0 Q28306123-75688CCB-28AC-45BD-8F21-1428798A976C Q28361871-9B117C6D-350A-4D2D-AF4D-6B300321B0F9 Q28487916-FE35D6E7-8D52-407F-BBC0-C63D59BA84DB Q28575076-F95852C2-DE0C-47C7-B000-7F41DAA641A4 Q28588420-257AB25A-0655-40C7-8944-E58423C8FD5D Q28592376-C32BA266-3D50-4C49-9708-6222F203826F Q30371147-10944D15-37DE-4017-A457-E64FA91EAA75 Q30491276-BECF3C99-5109-4AAD-9BC8-E4474B362EE4 Q30498969-17D53E32-FB0B-4E92-BB4E-8BD43C4477FB Q30592602-0F012062-E79D-4CE8-BC30-AF7733C40BE8 Q30609102-2C10E3C6-0D66-402F-B152-403F3C22A719

P2860

Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2.

http://www.wikidata.org/entity/Q34381015

description

1996 nî lūn-bûn

@nan

1996 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

1996 թվականի հունիսին հրատարակված գիտական հոդված

@hy

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

name

Mutations in the activin recep ...... rrhagic telangiectasia type 2.

@ast

Mutations in the activin recep ...... rrhagic telangiectasia type 2.

@en

Mutations in the activin recep ...... rrhagic telangiectasia type 2.

@nl

type

label

Mutations in the activin recep ...... rrhagic telangiectasia type 2.

@ast

Mutations in the activin recep ...... rrhagic telangiectasia type 2.

@en

Mutations in the activin recep ...... rrhagic telangiectasia type 2.

@nl

prefLabel

Mutations in the activin recep ...... rrhagic telangiectasia type 2.

@ast

Mutations in the activin recep ...... rrhagic telangiectasia type 2.

@en

Mutations in the activin recep ...... rrhagic telangiectasia type 2.

@nl

P1433

Q34381015-2465CD65-3BFA-4696-8100-E369A7BEF1DF

P1476

Q34381015-2096074D-1D4A-43BF-A930-03C0E7FFF5F1

P2093

Q34381015-07A7522E-746B-4B85-817D-F9BFBBD76CBF

Q34381015-17348D3D-28B8-44F0-8C0B-E0C0D9CA20C9

Q34381015-2C395DB0-2D32-4491-B188-14A251A7DB15

Q34381015-3C58D8E3-B86D-49B8-AA8B-371B11D19A3D

Q34381015-4F03B0FA-9ACA-44A5-AFD1-6BD6D3D285AF

Q34381015-72F53882-4310-43DF-901C-CA8710375F48

Q34381015-7A063344-C0A4-4FE6-AD7F-C13EFC18E188

Q34381015-99DE2934-2EB7-4948-A985-5A7D6D1319D3

Q34381015-9BB9F6CE-2DD7-4F36-9020-4D73A8F9D7BF

Q34381015-ACD4EAB5-8996-41C0-834A-81904799F0D3

P2888

Q34381015-E8F7CCD1-3D18-4E62-B7B7-9C46FC9CB7E7

P304

Q34381015-98D5A2DB-598C-4989-8455-4E6A0A42CB26

P31

Q34381015-A160DBD2-4595-4FD1-B040-E01BC93C11BC

P356

Q34381015-88F392F1-EE7A-48EC-AD83-BCCFE69B4DD9

P407

Q34381015-C3D5FB68-A127-45D5-BB63-5FD2B9F203EA

P433

Q34381015-F0D427D2-80BF-4347-9661-18000F4258CC

P478

Q34381015-9EF1D4F1-CA34-4423-AA45-197BE81CB2B4

P577

Q34381015-A996AC31-0EE5-4F08-BE49-06DB70655CA4

P698

Q34381015-62C01B3B-A707-4C4E-BA21-9585860A22BF

P356

P1433

Nature Genetics

P1476

Mutations in the activin recep ...... rrhagic telangiectasia type 2.

@en

P2093

Attisano L

http://www.w3.org/2001/XMLSchema#string

Baldwin MA

http://www.w3.org/2001/XMLSchema#string

Berg JN

http://www.w3.org/2001/XMLSchema#string

Diamond A

http://www.w3.org/2001/XMLSchema#string

Gallione CJ

http://www.w3.org/2001/XMLSchema#string

Guttmacher AE

http://www.w3.org/2001/XMLSchema#string

Jackson CE

http://www.w3.org/2001/XMLSchema#string

Johnson DW

http://www.w3.org/2001/XMLSchema#string

Kucherlapati R

http://www.w3.org/2001/XMLSchema#string

Marchuk DA

http://www.w3.org/2001/XMLSchema#string

P2888

P304

189-195

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NG0696-189

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

1996-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8640225

http://www.w3.org/2001/XMLSchema#string